Safety and Immunogenicity Study of SARS-CoV-2 Nanoparticle Vaccine (GBP510) Adjuvanted With Aluminum Hydroxide (COVID-19)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04742738 |
|
Recruitment Status :
Recruiting
First Posted : February 8, 2021
Last Update Posted : February 8, 2021
|
Sponsor:
SK Bioscience Co., Ltd.
Collaborator:
Coalition for Epidemic Preparedness Innovations
Information provided by (Responsible Party):
SK Chemicals Co., Ltd. ( SK Bioscience Co., Ltd. )
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | August 2021 |
| Estimated Study Completion Date : | April 2022 |